2023
DOI: 10.1159/000534642
|View full text |Cite
|
Sign up to set email alerts
|

Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients

Emma Di Poi,
GianLuca Colussi,
Martina Bertoni
et al.

Abstract: <b><i>Introduction:</i></b> If properly evaluated, chronic kidney disease can be found in up to 50% of patients with systemic sclerosis (SSc). The renal resistive index (RRI) is a marker of intrarenal vascular resistance and can predict SSc-associated vasculopathy. This study aimed to determine the impact of bosentan, a nonselective endothelin-1 receptor antagonist, on RRI and kidney function in SSc patients with recurrent digital ulcers. <b><i>Methods:</i></b> T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 41 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?